Skip to content

NIH Websites Are Changing

NIH is moving the launch of its new website to the fall to ensure the best possible experience for everyone who relies on our websites for health information, research, funding opportunities, and other resources.
Get the Latest Updates and FAQs

Patient-Specific Stem Cells and Personalized Gene Therapy

Patients’ own cells transformed into model for studying disease and developing potential treatment
July 10, 2014
Gene Therapy Genetics Rare Diseases Retinitis Pigmentosa Stem Cells
Translational Research
Grantee

Columbia University Medical Center (CUMC) researchers have created a way to develop personalized gene therapies for patients with retinitis pigmentosa (RP), a leading cause of vision loss. The approach, the first of its kind, takes advantage of induced pluripotent stem (iPS) cell technology to transform skin cells into retinal cells, which are then used as a patient-specific model for disease study and preclinical testing.

Read more at CUMC News
Back to top